Related Experiment Video
Updated: May 22, 2026

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus
Published on: January 28, 2019
Rotavirus infection and the current status of rotavirus vaccines
Shou-Chien Chen1, Lia-Beng Tan, Li-Min Huang
1Department of Family Medicine, Da-Chien General Hospital, Miaoli, Taiwan.
Abstract:
Among children, rotaviruses are the most common cause of severe gastroenteritis worldwide and of diarrheal deaths in developing countries. Current vaccines (e.g., Rotarix, GlaxoSmithKline Biologicals; RotaTeq, Merck and Company) effectively reduce rotaviral gastroenteritis, emergency department visits, and hospitalizations. The tremendous burden of rotavirus-related diarrhea in children across the world continues to drive the remarkable pace of vaccine development. This review assesses the global epidemiological and economic burden of rotavirus diseases, summarizes the relevant principles of the development of rotavirus vaccines, and presents data on the efficacy and effectiveness of currently licensed vaccines in both developed and developing countries.
Related Concept Videos
Vaccinations
Bacterial Gastroenteritis
Size and Structure of Viral Genomes
Vaccines

